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Gastrointestinal bleedingAbstract Acute gastrointestinal (GI) bleeding is an important cause of emergency hospital
admissions, with its related morbidity and mortality. The availability of endoscopic equipment has
had an important effect on the rapid identification and treatment of the bleeding source. Multidetector
computed tomography (MDCT) allows direct demonstration and visualization of the bleeding source
and its characterization. The information provided by MDCT angiography before attempts at
therapeutic angiographic procedures leads to faster selective catheterization of bleeding vessels.
The purpose of this study was to show the role of MDCT and catheter embolization in management of
acute GI bleeding.
Materials and methods: This is a retrospective study that included 57 patients referred in 4 years with
active gastrointestinal bleeding.
MDCT was performed in 43 cases, while 14 patients didn’t have CT angiography and proceeded
straight to angiography.
Results: 37 patients had positive MDCT findings, of which 27 cases had positive bleed on angiogra-
phy, and 10 did not show active bleeding on angiography. 6 patients had a negative MDCT and did
not proceed to angiography. 14 patients did not have a MDCT and proceeded straight to angiography;
6 of them showed active bleeding on angiography.
Conclusion: MDCT is an excellent technique before angiography and embolization in cases with acute
gastrointestinal bleeding. Transcatheter embolization is an effective tool for control of GI bleed.
 2015 The Authors. Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Gastrointestinal (GI) hemorrhage is a medical emergency. Its
associated mortality is approximately 10%, a figure which
has remained largely unchanged over the past decades. The
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higher than that for lower GI bleeding.1
Upper GI bleeding occurs proximal to the ligament of
Treitz (which connects the fourth portion of the duodenum
to the diaphragm) and arises from the esophagus, stomach,
or duodenum.2 About half the cases of upper GI bleeding
are caused by gastric and duodenal ulcers.3 Lower GI bleeding
involves the small bowel, colon, or rectum. Depending on the
amount of blood loss and location, the clinical presentation
varies considerably.2
Patients with upper GI hemorrhage may present with
hematemesis, coffee ground vomiting, melena, or hema-
tochezia if the hemorrhage is severe. Patients with lower GI
bleeding may present with melena, hematochezia, or rectal
bleeding. Melena usually indicates blood that has been in the
GI tract for at least 8 h. Melena is four times more likely to
come from upper GI bleeding than from the lower GI tract.
Hematochezia (bright red stool) is the sign of fast-moving
active bleeding and is found six times more frequently in lower
GI bleeding.4
1.1. Multidetector CT
General advantages of CT scanning include its wide availabil-
ity and the added diagnostic yield of cross-sectional imaging.5
A recent in vitro study found the threshold for detecting
bleeding with contrast material enhanced multidetector CT
to be 0.35 mL/min. Multidetector CT allows arterial phase
scanning of the whole abdomen, and contrast material
extravasation can be revealed in the small bowel, which is an
anatomic region not readily amenable to conventional
endoscopy.6
The sensitivity of CT for diagnosing the source of GI
bleeding has been shown to be higher in patients with active
hemorrhage (91–92%) than in those with obscure GI bleeding
(45–47%).7–9
1.2. Radionuclide scintigraphy
Radionuclide scintigraphy that is most commonly performed
with technetium 99 m (99mTc)–labeled red blood cells (RBCs)
is often used as a screening test before angiography because it is
noninvasive and more sensitive (bleeding at a rate of 0.05–
0.1 cc per minute can be detected). It also can be repeated in the
setting of intermittent bleeding. However, the ability of radionu-
clide scanning to localize the bleeding source correctly varies
widely in the literature. A significant disadvantage of radionu-
clide scintigraphy is the lack of therapeutic possibilities.5
1.3. Angiography and transcatheter embolization
Angiography is the only radiographic modality that can be
both diagnostic and therapeutic. Bleeding rates 0.5–1 cc per
minute can be detected with angiography. Successful localiza-
tion of bleeding is highly dependent on the rate of bleeding at
the time of the examination.5
Superselective angiography and transcatheter embolization
(SATE) has traditionally been indicated in those patients who
are considered poor candidates for surgery. Interventional
radiologic expertise has improved significantly along with
improvements in coaxial catheters and embolic agents(microcoils, gelfoams, and pledgets). These improved systems
allow better navigation and localization of arterial bleeding
and treatment of small caliber vessels with a decreased risk
of ischemic injury. In addition, SATE is a less invasive option
than is surgery. For these reasons, radiologists now argue that
SATE is a safe and effective treatment option that should be
considered in a wider spectrum of patients.10
2. Material and methods
The study included 57 patients referred with active gastroin-
testinal bleeding in 4 years.
CTA was performed in 43 cases. 37 patients had positive
CTA, of which 27 cases had positive bleed on angiography,
and 10 did not show active bleeding on angiography. 6 patients
had a negative CTA and did not proceed to angiography. 14
patients did not have a CTA and proceeded straight to angiog-
raphy; 6 of them showed active bleeding on angiography.
The equipment used for CTA was Toshiba Aquillon 128
MDCT unit kV/effective mAs/rotation time (s): 120 kV/225
effective mAs/0.35 s; slice thickness 0.5 mm.
CTA was done without prior oral administration of water
or contrast material. Active contrast material extravasation
within the bowel lumen is obscured by oral contrast material,
leading to false-negative results. Intraluminal water may be
helpful in finding the cause of acute GI bleeding, but it might
also lead to dilution of extravasated contrast agent, leading to
false-negative results.
The CT examination was performed first, with a noncon-
trast scan of the abdomen, followed by contrast-enhanced
phases CT at 45 s, 70 s after an injection of 120–150 mL of
nonionic contrast medium (350 mg I/mL) given at the antecu-
bital vein at a rate of 4 mL/s.
The data acquired were transferred to a workstation (Osirix
software) for multiplanar reconstruction.
All angiographic procedures were performed with digital
subtraction imaging, and standard five French catheters
(Simmons I, II or Cobra Glidecath, Terumo Europe, Leuven,
Belgium and Simmons II or Cobra, Cook Medical, Bjaever-
skov, Denmark) and iopromidum (Ultravist, Schering, Machelen,
Belgium) were used as contrast material.
The embolization procedure was performed in all patients
with the use of a microcatheter (Progreat 2.7 Fr, Terumo
Europe, Leuven, Belgium). The embolic agents used were as
follows: microcoils (Boston Scientific or Cook Medical) were
used in 32 patients, and a 20 mm  8 cm stent graft (Cook
Medical, Bjaeverskov, Denmark) was used in one patient.
3. Results
This study included 57 patients, 33 men and 24 women.
Their average age was 69.9 and age range from 32 to
91 years.
3.1. CT angiography
Out of the 57 patients in this study, CTA was performed in 43
cases. 37 patients had positive CTA, of which 27 cases had
positive bleed on angiography, and 10 did not show active
bleeding on angiography. 6 patients had a negative CTA and
did not proceed to angiography.
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ceeded straight to angiography; 6 of them showed active bleed-
ing on angiography.
3.2. Conventional catheter angiography
Out of the 57 patients in this study 51 patients had
angiography:
 33 showed active bleeding and were treated with emboliza-
tion and/or stent graft successfully with no immediate
complications.
 18 patients had a negative angiogram.
 The remaining 6 patients did not proceed to angiography
because they had a negative CTA.
The 33 patients with active bleeding were distributed as
following:
 10/33 of the embolized cases were post-operative; the com-
monest cause was post-ERCP sphincterotomy (3 cases) fol-
lowed by post-colonoscopy biopsy (2 cases).Figure 1 Post left renal biopsy; bleeding from Wandering artery of D
active bleeding at the site of the marginal artery (arrow). (b) Digital
bleeding active (arrow). (c) Digital subtraction angiography showing
subtraction check angiogram: showing no contrast extravasation, den In 5/33 of the embolized cases there was spontaneous GI
bleeding in patient on thrombolysis, anticoagulation or
hemophilic patients.
 In 3/33 the underlying cause for bleeding was pancreatitis
 3/33 patients had duodenal ulcer.
 1/33 had bleeding rectal cancer.
 1/33 had bleeding gastric ulcer in hiatus hernia.
 In 10/33 patients there was no underlying cause for
bleeding.
Coils were used for embolization in all cases apart from the
case of aorto-enteric fistula where a stent-graft was used.
The initial technical success rate (effective embolization of
the target vessel) was 100%.
There was one recurrent bleeding in a case of bleeding with
no underlying cause in the ascending colon (three days after
the initial successful embolization) which required a second
embolization, which controlled the bleeding effectively.
No immediate post-procedural complications were encoun-
tered regarding puncture site hematoma or coil migration.
There were no reported cases of postembolic infarction
(see Figs. 1–4).rummond (marginal artery). (a) CT angiography showing site of
subtraction IMA selective angiography showing the site of active
coils deployed proximal and distal to bleeding point. (d) Digital
oting successful embolization.
Figure 2 Sigmoid bleeding in 85 yrs old female patient. (a) Contrast enhanced CT in arterial phase showing high density contrast within
the sigmoid colon in keeping with active bleeding. (b) Superselective angiography showing severe narrowing of the distal sigmoid branches
due to compensatory arterial spasm. (c) Superselective angiography after coil insertion showing complete embolization.
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Upper GI endoscopy is currently considered the first-line diag-
nostic and therapeutic modality for direct localization and
local treatment of upper GI bleeding.11 However, the distal
duodenum and most of the small bowel cannot be adequately
assessed with conventional endoscopy.12 Despite adequate
colon preparation, urgent colonoscopy may help identify a
definitive bleeding source in only 13% of patients and a prob-
able bleeding source in 67%.13
In cases of endoscopic failure, therapeutic options include
surgery and transcatheter therapy. Surgery is associated with
high mortality rates of 15% up to 30% in emergent cases;
therefore less invasive therapies, such as transcatheter
embolotherapy have become more and more attractive as a
rescue strategy in cases where endoscopic hemostasis is not fea-
sible or unsuccessful.14
Transcatheter embolization was first described as an alter-
native to surgery in patients with UGI hemorrhage by Rosch
in 1972. In the intervening years, there has been strong support
in the literature advocating the use of transcatheter emboliza-
tion as a method to control UGI bleeding. It is most useful in
patients who are poor surgical candidates due to advanced age
or severe underlying medical conditions, or in patients with
less common causes of bleeding, such as hemobilia or ruptured
pseudoaneurysm complicating pancreatitis.15
Another advantage of transarterial embolization (TAE) is
that most of the patients with recurrent bleeding after initial
treatment with surgery or TAE could be effectively treated
with TAE, thus avoiding a second surgical procedure.16
In our study scanning was performed with a 128-slice CT
system. We used a multi-phase acquisition, which was designed
to optimize detection of most of the common causes of GI
bleeding. Huprich et al., and Jaeckle et al., have recommended
a triple-phase acquisition protocol to increase the sensitivity
for the detection of GI bleeding.9,17
In our study contrast material (350 mg I/ml) was injected at
the rate of 4–5 ml/s. This agrees with Huprich et al., contrast
material (300 mg I/ml) was injected with a flow rate of
4 ml/s, and 64-slice MDCT was able to identify the bleeding
source in 45% of patients.9Our study included 57 patients; CTA was performed in 43
cases. 37 patients had positive CTA (86.05%), of which 27
cases had positive bleed on angiography (62.7%), and 10 did
not show active bleeding on angiography. 6 patients had a neg-
ative CTA and did not proceed to angiography.
The remaining 14 patients did not have a CTA and pro-
ceeded straight to angiography; 6 of them showed active bleed-
ing on angiography
A total of 33 patients with active bleeding were embolized
(27 patients had positive CTA plus 6 patients didn’t have
CTA and proceeded straight to angiography).
10/33 of the embolized cases were post-operative (30.3%);
the commonest cause was post-ERCP sphincterotomy (3 cases)
followed by post-colonoscopy biopsy (2 cases). In 5/33 of the
embolized cases there was spontaneous GI bleeding (15.15%)
in patient on thrombolysis, anticoagulation or hemophilic
patients. In 3/33 the underlying cause for bleeding was pancre-
atitis (9.09%). 3/33 patients had duodenal ulcer (9.09%). 1/33
had bleeding rectal cancer (3.03%). 1/33 had bleeding gastric
ulcer (3.03%). In 10/33 patients there was no underlying cause
for bleeding (30.3%).
The initial technical success rate (effective embolization of
the target vessel) was 100% in our study. Funaki et al.18
achieved 96% hemostasis in a series of 25 patients.
Microcoils have become the agent of choice for many inter-
ventionalists. Thewide range of available coil sizes allows custom
selection of coil to match the vessel diameter. Because these coils
arehighly radiopaque, they canmore accuratelybedeployed.19 In
our study, all caseswere embolized using coils apart fromone case
of aorto-enteric fistula where a stent-graft was used.
Early surgical conversion because of embolization-induced
bowel ischemia is between 5% and 15% of cases. Re-bleeding
after an initially successful therapeutic embolization is also
acceptably low with recurrent lower GI bleeding rates of 10–
30% within the first month after successful therapeutic angiog-
raphy.14 In our study, there was recurrent bleeding in one case
(3%) of ascending colon bleeding of no underlying cause. In
this case, bleeding recurred three days after the initial success-
ful embolization, and it required a second embolization set-
ting; which controlled the bleeding effectively. None of our
cases required surgery post-embolization.
Figure 3 Bleeding from gastric ulcer within hiatus hernia. (a) CT arterial phase showing small focal active bleeding within hiatus hernia.
(b) Digital subtraction angiography with selective celiac angiography showing faint spot of active bleeding. (c) Digital subtraction
angiography with super-selective short gastric artery arising from splenic artery catheterization showing a spot of active bleeding.
(d) Digital subtraction angiography after coil embolization, showing successful control with no active bleeding.
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embolotherapy are supported in the literature. In our study,
no immediate post-procedural complications were encountered
regarding puncture site hematoma or coil migration. There
were no reported cases of delayed postembolic infarction.
We agree with Eriksson et al.16 who reported that none of their
patients demonstrated any complications in the short or long
term that could be related to the TAE procedure. Kuo et al.19
demonstrated the safety of superselective microcoil emboliza-
tion in 22 patients with no major ischemic complications.
In one of the cases, the patient had a blind percutaneous left
renal core biopsy in the morning and later on in the day he was
shocked and hypotensive; the patient was referred to interven-
tional radiology, and an MDCT was organized; the CT
showed active bleeding arising from the colon rather than
bleeding from the left kidney as would be expected from the
history of the patient. The explanation would be that there
was transfixation of the left kidney during biopsy with subse-quent injury to the arterial supply of the colon. This highlights
the value of MDCT for localizing the source of bleeding. In
this case, the bleeding site was identified at angiography to
be at the marginal artery and hence, distal embolization at that
level was done successfully using micro-coils. This agrees with
results of Evangelista et al.20, and Kuo et al.19 that a distal site
at the level of the vasa recta or marginal artery should be cho-
sen for embolization in order to minimize the region at risk for
ischemia.
Eriksson et al. found that the frequency of repeat bleeding
might be reduced if the bleeding site can be marked during gas-
troscopy with a metallic clip.16 In one of our cases, the patient
presented with upper GIT bleeding, and endoscopy showed
severe hemorrhage from a duodenal ulcer; the endoscopist
could not control the bleeding, but inserted a metallic clip at
the site of bleeding as a tag to guide embolization. In this case
an MDCT was not needed because the site of bleeding was
identified and tagged by the radio-opaque metallic clip.
Figure 4 Post retroperitoneal surgery severe hemoglobin drops
with aorto-enteric fistula. (a) CT arterial phase showing active
bleeding from iatrogenic aorto-enteric fistula with contrast seen in
the duodenum. (b) Digital subtraction angiography following
stent-graft insertion, showing successful control with no active
bleeding.
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MDCT angiography should be considered the primary imag-
ing modality in the diagnosis of active GI bleeding. A positive
MDCTA allows earlier targeted embolization, while a negative
MDCTA can prevent patients having an unnecessary high-risk
interventional procedure.Transcatheter embolization is an effective tool for control
of GI bleed and is less invasive than surgery. It has become
more attractive alternative in cases where endoscopic hemosta-
sis is not feasible or unsuccessful.
Conflict of Interest
Author states that there is no conflict of interest.
References
1. Kra¨mer SC, Go¨rich J, Rilinger N, et al. Embolization for
gastrointestinal hemorrhages. Eur Radiol 2000;10:802–5.
2. Scheffel H, Pfammatter T, Wildi S, Bauerfeind P, Marincek B,
Alkadhi H. Acute gastrointestinal bleeding: detection of source
and etiology with multi-detector-row CT. Eur Radiol 2007;17
(6):1555–65.
3. Loffroy R, Guiu B, D’Athis P, et al. Arterial embolotherapy for
endoscopically unmanageable acute gastroduodenal hemorrhage:
predictors of early rebleeding. Clin Gastroenterol Hepatol
2009;7:515–23.
4. Peura DA, Lanza FL, Gostout CJ, Foutch PG. The American
College of gastroenterology bleeding registry: preliminary findings.
Am J Gastroenterol 1997;92(6):924–8.
5. Strate LL, Naumann CR. The role of colonoscopy and radiolog-
ical procedures in the management of acute lower intestinal
bleeding. Clin Gastroenterol Hepatol 2010;8:333–43.
6. Jaeckle T, Stuber G, Hoffmann MH, Jeltsch M, Schmitz BL,
Aschoff AJ. Detection and localization of acute upper and lower
gastrointestinal (GI) bleeding with arterial phase multi-detector
row helical CT. Eur Radiol 2008;18(7):1406–13.
7. Yoon W, Jeong YY, Shin SS, et al. Acute massive gastrointestinal
bleeding: detection and localization with arterial phase multi-
detector row helical CT. Radiology 2006;239(1):160–7.
8. Jain TP, Gulati MS, Makharia GK, Bandhu S, Garg PK. CT
enteroclysis in the diagnosis of obscure gastrointestinal bleeding:
initial results. Clin Radiol 2007;62(7):660–7.
9. Huprich JE, Fletcher JG, Alexander JA, Fidler JL, Burton SS,
McCullough CH. Obscure gastrointestinal bleeding: evaluation
with 64-slice multiphase CT enterography—initial experience.
Radiology 2008;246(2):562–71.
10. Patel TH, Cordts PR, Abcarian P, Sawyer MA. Will transcatheter
embolotherapy replace surgery in the treatment of gastrointestinal
bleeding? Curr Surg 2001;58(3):323–7.
11. Laing CJ, Tobias T, Rosenblum DI, Banker WL, Tseng L,
Tamarkin SW. Acute gastrointestinal bleeding: emerging role of
multidetector CT angiography and review of current imaging
techniques. RadioGraphics 2007;27(4):1055–70.
12. Lee EW, Laberge JM. Differential diagnosis of gastrointestinal
bleeding. Tech Vasc Interv Radiol 2004;7(3):112–22.
13. Angtuaco TL, Reddy SK, Drapkin S, Harrell LE, Howden CW.
The utility of urgent colonoscopy in the evaluation of acute lower
gastrointestinal tract bleeding: a 2-year experience from a single
center. Am J Gastroenterol 2001;96(6):1782–5.
14. Maleux G, Roeflaer F, Heye S, et al. Long-term outcome of
transcatheter embolotherapy for acute lower gastrointestinal
hemorrhage. Am J Gastroenterol 2009;104:2042–6.
15. Kim SK, Duddalwar V. Failed endoscopic therapy and the
interventional radiologist: non-variceal upper gastrointestinal
bleeding. Tech Gastrointest Endosc 2005;7:148–55.
16. Eriksson LG, Ljungdahl M, Sundbom M, Nyman R. Tran-
scatheter arterial embolization versus surgery in the treatment of
upper gastrointestinal bleeding after therapeutic endoscopy fail-
ure. J Vasc Interv Radiol 2008;19:1413–8.
MDCT angiography and transcatheter embolization 32317. Jaeckle T, Stuber G, Hofmann MH, Freund W, Schmitz BL,
Aschof AJ. Acute gastrointestinal bleeding: value of MDCT.
Abdom Imag 2007;33:285–93.
18. Funaki B, Kostelic JK, Lorenz J, et al. Superselective microcoil
embolization of colonic hemorrhage. AJR Am J Roentgenol 2001;
177:829–36.19. Kuo WT, Lee DE, Saad WEA, Patel N, Sahler LG, Waldman DL.
Superselective microcoil embolization for the treatment of lower
gastrointestinal hemorrhage. J Vasc Interv Radiol 2003;14:1503–9.
20. Evangelista PT, Hallisey MJ. Transcatheter embolization for acute
lower gastrointestinal hemorrhage. J Vasc Interv Radiol 2000;11:
601–6.
